Publication details

Pokroky v léčbě akutní lymfoblastické leukemie dospělých

Title in English Advancements in the treatment of adult acute lymphoblastic leukaemia
Authors

HRABOVSKÝ Štěpán FOLBER František ŠÁLEK C. HORÁČEK J. M. MAYER Jiří DOUBEK Michael

Year of publication 2015
Type Article in Periodical
Magazine / Source Transfuze a hematologie dnes
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords acute lymphoblastic leukaemia; minimal residual disease; BCR-ABL-like ALL; Ikaros; NOTCH1; ETP-ALL; monoclonal antibodies
Description Acute lymphoblastic leukaemia (ALL) is predominantly a childhood disease and its incidence in adults is low. The prognosis and treatment outcome in adults are less satisfactory than in children. However, many new discoveries have been made recently. This review describes diagnostic procedures and treatment options in adult ALL. It focuses on minimal residual disease and its prognostic significance; on several new genetic abnormalities, such as IKZF1 (Ikaros) and NOTCH1 gene mutations and on the new prognostic categories of Ph-like (BCR-ABL1-like) ALL and early T-cell precursor (ETP) ALL. An overview of new drugs currently being tested in clinical trials, especially monoclonal antibodies and antibody-drug conjugates, is also presented.

You are running an old browser version. We recommend updating your browser to its latest version.

More info